Notably, post-mortem studies have shown that VMAT2 expression is reduced in the SNpc of PD patients, further reinforcing the link between impaired vesicular storage of DA, elevated cytosolic DA, and enhanced NM formation. Here, SLC18A2 is linked to Parkinson disease.